F. Danel et al., OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, fromtwo Pseudomonas aeruginosa isolates, ANTIM AG CH, 42(12), 1998, pp. 3117-3122
Two extended-spectrum mutants of the class D beta-lactamase OXA-10 (PSE-2)
from Pseudomonas aeruginosa isolates obtained in Ankara, Turkey, were descr
ibed previously and were designated OXA-11 and -14. P. aeruginosa 906 and 9
61, isolated at the same hospital, were highly resistant to ceftazidime (MI
C greater than or equal to 128 mu g/ml) and produced a p-lactamase with a p
i of 6.2. The MICs of ceftriaxone, cefoperazone, cefsulodin, and cefepime w
ere 4- to 16-fold above the typical values for P. aeruginosa, whereas the M
ICs of penicillins and cefotaxime were raised only marginally. Ceftazidime
MICs were not significantly reduced by clavulanate or tazobactam at 4 mu g/
ml. Ceftazidime resistance did not transfer conjugatively but was mobilized
to P. aeruginosa PU21 by plasmid pUZ8. Both isolates gave similar DNA rest
riction patterns, suggesting that they were replicates; moreover, they yiel
ded identically sized BamHI fragments that hybridized with a bla(OXA-10) pr
obe. DNA sequencing revealed that both isolates had the same new beta-lacta
mase, designated OXA-16, which differed from OXA-10 in having threonine ins
tead of alanine at position 124 and aspartate instead of glycine at positio
n 157. The latter change is also present in OXA-11 and -14 and seems critic
al to ceftazidime resistance. Kinetic parameters showed that OXA-16 enzyme
was very active against penicillins, cephaloridine, cefotaxime, and ceftria
xone, but hydrolysis of ceftazidime was not detected despite the ability of
the enzyme to confer resistance.